Référence:
20160789
Date de publication: 8 décembre 2016
Date de publication: 8 décembre 2016
Promoteur – Intermédiaire Financier
Acceptable Corporate(s)Lieu
Description
Capital expenditure investments related to medical technology
Objectifs
The project concerns the investment in a new parenteral unit in order to produce large volume parenteral solutions and small volume parenteral solutions.
Secteur(s)
- Industrie - Industrie manufacturière
Montant BEI envisagé (montant approximatif)
EUR 20 million
Coût total (montant approximatif)
EUR 42 million
Aspects environnementaux
The project falls under Annex II of Environmental Impact Assessment (EIA) Directive 2011/92/EU (implementation of an industrial facility for the production of pharmaceutical products). The project has been screened by the competent authorities and the EIA is currently under public consultation. Full environmental details will be assessed during the appraisal.
Passation des marchés
The promoter is a private company not operating in the utilities sector and is thus not covered by EU directives on procurement.
Statut
Signé - 30/06/2017